| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) | 
|---|
| 07/25/2007 | EP1809616A2 Synthesis of amino acid, n-carboxyanhydrides | 
| 07/25/2007 | EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | 
| 07/25/2007 | EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands | 
| 07/25/2007 | EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use | 
| 07/25/2007 | CN101006066A Arylcycloakyl-substituted alkanoic acid derivatives and its preparation method and uses as drug | 
| 07/24/2007 | US7247738 Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids | 
| 07/24/2007 | US7247649 e.g 1-[4-(4-{2-[2-(E)-(4-Chloro-2-fluoro-phenyl)-vinyl]-oxazol-4-ylmethoxy}-phenyl)-butyl]-1H-[1,2,3]triazole; inhibitors of the HER (human epidermal growth factor receptors)-signalling pathway; antiprolirative; cancer | 
| 07/19/2007 | WO2007081479A1 Diaromatic amine derivatives as antioxidants | 
| 07/19/2007 | WO2007080882A1 Oxazolone derivative | 
| 07/19/2007 | WO2007079928A1 Substituted oxazole derivatives with an analgesic action | 
| 07/19/2007 | WO2007058338A3 Oxazole compound and pharmaceutical composition | 
| 07/19/2007 | WO2006138660A3 Sphingosine kinase inhibitors | 
| 07/19/2007 | US20070167503 Substituted benzoxazoles as estrogenic agents | 
| 07/19/2007 | US20070167499 Biaryl linked hydroxamates: preparation and pharmaceutical applications | 
| 07/19/2007 | US20070167452 Therapeutic amide derivatives | 
| 07/19/2007 | US20070167444 Benzamide derivative or salt thereof | 
| 07/19/2007 | CA2636625A1 Oxazolone derivative | 
| 07/19/2007 | CA2635083A1 Oxazolidinone derivatives as cetp inhibitors | 
| 07/19/2007 | CA2635010A1 Oxazolidinone derivatives as cetp inhibitors | 
| 07/19/2007 | CA2634566A1 Substituted oxazole derivatives with an analgesic action | 
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase | 
| 07/18/2007 | EP1508566B1 (2s)-2-ethylphenylpropionic acid derivative | 
| 07/18/2007 | CN101001846A Novel alkynyl derivatives as modulators of metabotropic glutamate receptors | 
| 07/18/2007 | CN101001826A Method for producing optically active cyclopropanecarboxylate compound | 
| 07/17/2007 | US7244851 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies | 
| 07/17/2007 | US7244763 Compounds that modulate PPAR activity and methods of preparation | 
| 07/17/2007 | US7244755 Hydroxypropylamines | 
| 07/17/2007 | US7244754 For therapy of Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease | 
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors | 
| 07/17/2007 | CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors | 
| 07/17/2007 | CA2191073C Tetrahydroindeno[1,2-d][1,3,2]oxazaboroles and their use as enantioselective catalysts | 
| 07/12/2007 | WO2007079186A2 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors | 
| 07/12/2007 | WO2007078523A2 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders | 
| 07/12/2007 | US20070161693 6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione's as proteasome inhibitors, used to treat conditions mediated directly by the proteolytic function of the proteasome such as muscle wasting | 
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists | 
| 07/12/2007 | US20070161112 Cell biology, neurology, nutrition, immunology, reproductive biology, cancer and proteomics; facilitate binding, detecting, monitoring and quantitating of heavy metalnovel luminescence-based materials ; | 
| 07/11/2007 | EP1806346A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | 
| 07/11/2007 | EP1806344A1 Optically active 4,4-disubstituted oxazolidine derivative and method for producing same | 
| 07/11/2007 | EP1805152A2 Insecticidal 3-(dihaloalkenyl) phenyl derivatives | 
| 07/10/2007 | US7241900 Synthesis of indole thiazole compounds as ligands for the Ah receptor | 
| 07/10/2007 | US7241785 Five-membered heterocyclic alkanoic acid derivative | 
| 07/10/2007 | US7241784 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient | 
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | 
| 07/10/2007 | US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity | 
| 07/05/2007 | WO2007075870A2 Processes for taxane derivatives and intermediates useful therein | 
| 07/05/2007 | WO2007073699A1 5,5'-linked 1,1'-biphenyl axial chiral ligands and preparation methods thereof | 
| 07/05/2007 | WO2007056366A3 Compounds and compositions as ppar modulators | 
| 07/05/2007 | US20070155975 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts | 
| 07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS | 
| 07/05/2007 | US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression | 
| 07/05/2007 | US20070155808 G Protein-Coupled Receptors (GPR40); insulin secretagogue; diabetes; 3-[4-[[4-[[(2-Phenylethyl)(4-phenyl-1,3-thiazol-2-yl)amino]methyl]benzyl]oxy]phenyl]propanoic acid | 
| 07/05/2007 | US20070155798 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate | 
| 07/05/2007 | US20070155633 containing oxazole substituent; provide deposit protection in addition to oxidation-corrosion protection; can also provide such protection while having only low levels of phosphorous; environmentally desirable | 
| 07/05/2007 | CA2634746A1 Processes for taxane derivatives and intermediates useful therein | 
| 07/04/2007 | EP1803713A2 Polymer-filler coupling additives | 
| 07/04/2007 | EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments | 
| 07/04/2007 | EP1802593A2 Polymer-filler coupling additives | 
| 07/04/2007 | EP1802583A1 Heterocyclic carbonyl compounds | 
| 07/04/2007 | EP1802566A1 Hexafluoroisopropanol substituted ether derivatives | 
| 07/04/2007 | CN1993363A 1,3-disubstituted heteroaryl nmda/nr2b antagonists | 
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors | 
| 07/04/2007 | CN1324019C New azadicyclo salt kind compound and its use in treating protein aging disease | 
| 07/04/2007 | CN1324017C Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives | 
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands | 
| 07/03/2007 | US7238835 Process for the preparation of substituted 2-(phenoxymethyl) benzoic acids | 
| 07/03/2007 | US7238814 For measuring vasodilation or changes in blood flow in a patient | 
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents | 
| 07/03/2007 | US7238716 Alkanoic acid derivatives process for their production and use thereof | 
| 07/03/2007 | US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties | 
| 07/03/2007 | CA2252465C Urea derivatives as inhibitors of impdh enzyme | 
| 06/28/2007 | WO2007073518A2 Compounds and methods for thiol-containing compound efflux and cancer treatment | 
| 06/28/2007 | WO2007073296A1 Heterocyclic gaba-b modulators | 
| 06/28/2007 | WO2007005531A3 Alkenyldiarylmethanes, fused analogs and syntheses thereof | 
| 06/28/2007 | US20070149803 Stabilizing the reaction of an alcohol with an olefinically unsaturated carboxylic acid or reactive derivative by performing the reaction in the presence of an oxazoline, such as 2-methyl-2-oxazoline; e.g., reacting methacrylic acid with a monoalkyl polyoxyethylene glycol | 
| 06/28/2007 | US20070149582 1-(Azolin-2-yl)amino-1,2-diphenylethane compounds for combating insects, arachnids and nematodes | 
| 06/28/2007 | US20070149531 Antiviral agents | 
| 06/28/2007 | US20070149530 Antiviral agents | 
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide | 
| 06/28/2007 | US20070144743 Tree mounted well flow interface device | 
| 06/28/2007 | DE102005061429A1 Substituierte Oxazol-Derivate Substituted oxazole derivatives | 
| 06/28/2007 | CA2669503A1 Compounds and methods for thiol-containing compound efflux and cancer treatment | 
| 06/28/2007 | CA2631991A1 Heterocyclic gaba-b modulators | 
| 06/27/2007 | EP1801107A1 Process for the preparation of phenylenebisisoxazoles | 
| 06/27/2007 | EP1799677A1 Oxazolidinone derivatives as antimicrobials | 
| 06/27/2007 | EP1799217A1 Compounds and methods of treating insulin resistance and cardiomyopathy | 
| 06/27/2007 | EP1567525B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors | 
| 06/27/2007 | CN1989141A Bicyclic heterocycles as HIV integrase inhibitors | 
| 06/27/2007 | CN1989115A Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses | 
| 06/26/2007 | US7235549 Benzamide, heteroarylamide and reverse amides | 
| 06/26/2007 | CA2200225C Asymmetric ligands useful for transition metal catalyzed bond forming reactions and epoxide reactions therewith | 
| 06/21/2007 | WO2007069773A1 A pharmaceutical composition comprising an amide derivative | 
| 06/21/2007 | US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives | 
| 06/21/2007 | US20070142390 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors | 
| 06/21/2007 | US20070142381 Calcium receptor modulating agents | 
| 06/21/2007 | US20070142246 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions | 
| 06/20/2007 | EP1797094A2 1,3-disubstituted heteroaryl nmda/nr2b antagonists | 
| 06/20/2007 | EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS | 
| 06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof | 
| 06/20/2007 | EP1599452B1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis | 
| 06/20/2007 | CN1982298A Hydro diamine compound, its production and use and composition containing it |